Pharmacogenomics (PGX) Market Report

China Pharmacogenomics (PGX) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 28, 2023
  • PAGES：154
  • REPORT CODE：GMM1763846
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pharmacogenomics defines how genes can affect a person's response to drugs. It is relatively a new field and combines pharmacology and genomics. The aim of pharmacogenomics is to develop effective and safe medications. Moreover by pharmacogenomics, drugs doses can be tailored to a person's genetic makeup. The field of pharmacogenomics is predicted to treat a wide range of health problems including cardiovascular diseases, Alzheimer disease, cancer, HIV/AIDS, and asthma, in near future.

    This report elaborates on the current development of the Pharmacogenomics (PGX) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pathway Genomics

    • Affymetrix, Inc

    • Transgenomic, Inc

    • Abbott Laboratories

    • GE Healthcare

    • GeneTech

    • Thermo Fisher Scientific

    • Illumina, Inc

    • Genset

    • GeneDx

    • OSI Pharmaceuticals

    By Type:

    • Polymerase Chain Reaction

    • Sequencing

    • Others

    • Microarray

    By Application:

    • Others

    • Neurological Disorders

    • Cardiology

    • Oncology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Pharmacogenomics (PGX) Market Overview 2018-2029

    • 1.1 China Pharmacogenomics (PGX) Industry Development Overview

    • 1.2 China Pharmacogenomics (PGX) Industry Development History

    • 1.3 China Pharmacogenomics (PGX) Industry Market Size (2018-2029)

    • 1.4 China Pharmacogenomics (PGX) Market Analysis by Type from Production Side

      • 1.4.1 China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (2018-2029)

      • 1.4.2 China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

      • 1.4.3 China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Microarray (2018-2029)

    • 1.5 China Pharmacogenomics (PGX) Market Analysis by Application from Consumption End

      • 1.5.1 China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

      • 1.5.3 China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

      • 1.5.4 China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • 1.6 China Pharmacogenomics (PGX) Market Analysis by Region

      • 1.6.1 North China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Pharmacogenomics (PGX) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Pharmacogenomics (PGX) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Pharmacogenomics (PGX) Market Status and Competition Analysis in 2023

      • 2.2.3 China Pharmacogenomics (PGX) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Pharmacogenomics (PGX) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Pharmacogenomics (PGX) Industry Development

    Chapter 3 Pharmacogenomics (PGX)Industry Chain Analysis

    • 3.1 Pharmacogenomics (PGX) Industry Chain

    • 3.2 Pharmacogenomics (PGX) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Pharmacogenomics (PGX) Market

    • 3.3 Pharmacogenomics (PGX) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Pharmacogenomics (PGX) Market

    Chapter 4 China Pharmacogenomics (PGX) Market, by Type

    • 4.1 China Pharmacogenomics (PGX) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Pharmacogenomics (PGX) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Pharmacogenomics (PGX) Production Volume and Growth Rate, by Type

      • 4.5.1 China Pharmacogenomics (PGX) Production Volume and Growth Rate of Polymerase Chain Reaction

      • 4.5.2 China Pharmacogenomics (PGX) Production Volume and Growth Rate of Sequencing

      • 4.5.3 China Pharmacogenomics (PGX) Production Volume and Growth Rate of Others

      • 4.5.4 China Pharmacogenomics (PGX) Production Volume and Growth Rate of Microarray

    Chapter 5 China Pharmacogenomics (PGX) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Pharmacogenomics (PGX) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Pharmacogenomics (PGX) Market Size and Growth Rate, by Application

      • 5.5.1 China Pharmacogenomics (PGX) Market Size and Growth Rate of Others

      • 5.5.2 China Pharmacogenomics (PGX) Market Size and Growth Rate of Neurological Disorders

      • 5.5.3 China Pharmacogenomics (PGX) Market Size and Growth Rate of Cardiology

      • 5.5.4 China Pharmacogenomics (PGX) Market Size and Growth Rate of Oncology

    Chapter 6 China Pharmacogenomics (PGX) Market, by Region

    • 6.1 China Pharmacogenomics (PGX) Production Volume and Production Value, by Region

    • 6.2 China Pharmacogenomics (PGX) Sales Volume and Sales Value, by Region

    Chapter 7 North China Pharmacogenomics (PGX) Market Analysis

    • 7.1 North China Pharmacogenomics (PGX) Market, by Type

    • 7.2 North China Pharmacogenomics (PGX) Market, by Application

    Chapter 8 Central China Pharmacogenomics (PGX) Market Analysis

    • 8.1 Central China Pharmacogenomics (PGX) Market, by Type

    • 8.2 Central China Pharmacogenomics (PGX) Market, by Application

    Chapter 9 South China Pharmacogenomics (PGX) Market Analysis

    • 9.1 South China Pharmacogenomics (PGX) Market, by Type

    • 9.2 South China Pharmacogenomics (PGX) Market, by Application

    Chapter 10 East China Pharmacogenomics (PGX) Market Analysis

    • 10.1 East China Pharmacogenomics (PGX) Market, by Type

    • 10.2 East China Pharmacogenomics (PGX) Market, by Application

    Chapter 11 Northeast China Pharmacogenomics (PGX) Market Analysis

    • 11.1 Northeast China Pharmacogenomics (PGX) Market, by Type

    • 11.2 Northeast China Pharmacogenomics (PGX) Market, by Application

    Chapter 12 Southwest China Pharmacogenomics (PGX) Market Analysis

    • 12.1 Southwest China Pharmacogenomics (PGX) Market, by Type

    • 12.2 Southwest China Pharmacogenomics (PGX) Market, by Application

    Chapter 13 Northwest China Pharmacogenomics (PGX) Market Analysis

    • 13.1 Northwest China Pharmacogenomics (PGX) Market, by Type

    • 13.2 Northwest China Pharmacogenomics (PGX) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pathway Genomics

        • 14.1.1 Pathway Genomics Company Profile

        • 14.1.2 Pathway Genomics Pharmacogenomics (PGX) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Affymetrix, Inc

        • 14.2.1 Affymetrix, Inc Company Profile

        • 14.2.2 Affymetrix, Inc Pharmacogenomics (PGX) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Transgenomic, Inc

        • 14.3.1 Transgenomic, Inc Company Profile

        • 14.3.2 Transgenomic, Inc Pharmacogenomics (PGX) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Abbott Laboratories

        • 14.4.1 Abbott Laboratories Company Profile

        • 14.4.2 Abbott Laboratories Pharmacogenomics (PGX) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 GE Healthcare

        • 14.5.1 GE Healthcare Company Profile

        • 14.5.2 GE Healthcare Pharmacogenomics (PGX) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GeneTech

        • 14.6.1 GeneTech Company Profile

        • 14.6.2 GeneTech Pharmacogenomics (PGX) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Thermo Fisher Scientific

        • 14.7.1 Thermo Fisher Scientific Company Profile

        • 14.7.2 Thermo Fisher Scientific Pharmacogenomics (PGX) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Illumina, Inc

        • 14.8.1 Illumina, Inc Company Profile

        • 14.8.2 Illumina, Inc Pharmacogenomics (PGX) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Genset

        • 14.9.1 Genset Company Profile

        • 14.9.2 Genset Pharmacogenomics (PGX) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GeneDx

        • 14.10.1 GeneDx Company Profile

        • 14.10.2 GeneDx Pharmacogenomics (PGX) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 OSI Pharmaceuticals

        • 14.11.1 OSI Pharmaceuticals Company Profile

        • 14.11.2 OSI Pharmaceuticals Pharmacogenomics (PGX) Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Pharmacogenomics (PGX) Industry Research Conclusions

    • 15.2 Pharmacogenomics (PGX) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Pharmacogenomics (PGX) Industry Market Size (2018-2029)

    • Figure China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Polymerase Chain Reaction (2018-2029)

    • Figure China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

    • Figure China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Pharmacogenomics (PGX) Production Volume, Production Value and Growth Rate of Microarray (2018-2029)

    • Figure China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

    • Figure China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

    • Figure China Pharmacogenomics (PGX) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure North China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure Central China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure South China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure East China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Pharmacogenomics (PGX) Market Size and Growth Rate from 2018-2029

    • Figure Pharmacogenomics (PGX) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Pharmacogenomics (PGX) Market Share by Type in 2018

    • Figure China Pharmacogenomics (PGX) Market Share by Type in 2023

    • Figure China Pharmacogenomics (PGX) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Volume and Growth Rate of Polymerase Chain Reaction (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Volume and Growth Rate of Sequencing (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Volume and Growth Rate of Microarray (2018-2023)

    • Figure China Pharmacogenomics (PGX) Market Share by Application in 2018

    • Figure China Pharmacogenomics (PGX) Market Share by Application in 2023

    • Figure China Pharmacogenomics (PGX) Total Market Size and Growth Rate from Consumption End

    • Figure China Pharmacogenomics (PGX) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Pharmacogenomics (PGX) Market Size and Growth Rate of Neurological Disorders (2018-2023)

    • Figure China Pharmacogenomics (PGX) Market Size and Growth Rate of Cardiology (2018-2023)

    • Figure China Pharmacogenomics (PGX) Market Size and Growth Rate of Oncology (2018-2023)

    • Table China Pharmacogenomics (PGX) Production Volume by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Production Volume Share by Region (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Volume Share by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Production Value by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Production Value Share by Region (2018-2023)

    • Figure China Pharmacogenomics (PGX) Production Value Share by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Sales Volume by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Sales Volume Share by Region (2018-2023)

    • Figure China Pharmacogenomics (PGX) Sales Volume Share by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Sales Value by Region (2018-2023)

    • Table China Pharmacogenomics (PGX) Sales Value Share by Region (2018-2023)

    • Figure China Pharmacogenomics (PGX) Sales Value Share by Region (2018-2023)

    • Table North China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table North China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure North China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table North China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table North China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure North China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table Central China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table Central China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure Central China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table Central China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table Central China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure Central China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table South China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table South China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure South China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table South China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table South China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure South China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table East China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table East China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure East China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table East China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table East China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure East China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table Northeast China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table Northeast China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table Northeast China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table Southwest China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table Southwest China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table Southwest China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Pharmacogenomics (PGX) Production Volume by Type (2018-2023)

    • Table Northwest China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Pharmacogenomics (PGX) Production Volume Share by Type (2018-2023)

    • Table Northwest China Pharmacogenomics (PGX) Sales Volume by Application (2018-2023)

    • Table Northwest China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Pharmacogenomics (PGX) Sales Volume Share by Application (2018-2023)

    • Table Pathway Genomics Company Profile

    • Table Pathway Genomics Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Affymetrix, Inc Company Profile

    • Table Affymetrix, Inc Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Transgenomic, Inc Company Profile

    • Table Transgenomic, Inc Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table GE Healthcare Company Profile

    • Table GE Healthcare Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table GeneTech Company Profile

    • Table GeneTech Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Company Profile

    • Table Thermo Fisher Scientific Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Illumina, Inc Company Profile

    • Table Illumina, Inc Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table Genset Company Profile

    • Table Genset Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table GeneDx Company Profile

    • Table GeneDx Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)

    • Table OSI Pharmaceuticals Company Profile

    • Table OSI Pharmaceuticals Pharmacogenomics (PGX) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US